Intra-patient variability in tacrolimus exposure in pediatric liver transplant recipients: Evolution, risk factors, and impact on patient outcomes.

Charlotte DefrancqNika De WildeAnn RaesStephanie Van BiervlietSaskia Vande VeldeMyriam Van WinckelRuth De BruyneAgnieszka Prytuła

Published in: Pediatric transplantation (2019)

Our results highlight the impact of biological factors on TAC IPV during the early LT follow-up and later also therapy adherence. High TAC IPV may be associated with adverse patient outcomes.

Keyphrases

intimate partner violence
risk factors
case report
type diabetes
emergency department
glycemic control
adverse drug
insulin resistance
stem cells
adipose tissue
cell therapy
replacement therapy
drug induced